Status:
COMPLETED
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Frontotemporal Dementia
Huntington Disease
Eligibility:
All Genders
40-85 years
Brief Summary
Behavioural disorders are very common right from the initial stage of dementia and contribute to loss of autonomy. Behavioural dysexecutive disorders have a particular status due to their prevalence a...
Eligibility Criteria
Inclusion
- Support to the consultation memory for a neurological disease ( frontotemporal dementia , vascular dementia , Alzheimer's disease , mild cognitive disorder, Huntington's disease ( with genetic diagnosis confirmed : number of CAG triplets \> 36 symptomatic : UHDRS score ≥5 ) with MMS \> 15
- Age 40 to 85 years
- French
- Informing reliable
- Agreeing to participate in the study.
Exclusion
- Presence of other disease disturbing behavior ( current depressive syndrome , schizophrenia, psychosis , past psychiatric disorders requiring a stay \> 2 days in a specialized environment ) or cognition (mental retardation , illiteracy , respiratory failure, kidney , liver , heart ) or preventing the realization of the tests ( perceptual or motor deficit ) intrecérébrale pacing therapy or stem cell transplant , patient protected ( under supervision or guardianship ) , pregnant and / or breastfeeding and lack of consent
Key Trial Info
Start Date :
January 29 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 28 2018
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT02819700
Start Date
January 29 2013
End Date
January 28 2018
Last Update
July 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80054
2
CHU Strasbourg
Strasbourg, France, 67091